These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16569339)

  • 1. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood.
    Lazarova P; Wu Q; Kvalheim G; Suo Z; Haakenstad KW; Metodiev K; Nesland JM
    Int J Immunopathol Pharmacol; 2006; 19(1):49-56. PubMed ID: 16569339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
    Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
    Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
    Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P
    Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
    de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
    Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and plasticity of CD133+ hematopoietic stem cells.
    Handgretinger R; Gordon PR; Leimig T; Chen X; Buhring HJ; Niethammer D; Kuci S
    Ann N Y Acad Sci; 2003 May; 996():141-51. PubMed ID: 12799292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells.
    Gordon PR; Leimig T; Babarin-Dorner A; Houston J; Holladay M; Mueller I; Geiger T; Handgretinger R
    Bone Marrow Transplant; 2003 Jan; 31(1):17-22. PubMed ID: 12621502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation and differentiation potential of CD133+ and CD34+ populations from the bone marrow and mobilized peripheral blood.
    Koutna I; Peterkova M; Simara P; Stejskal S; Tesarova L; Kozubek M
    Ann Hematol; 2011 Feb; 90(2):127-37. PubMed ID: 20821012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells.
    Pomyje J; Zivný J; Sefc L; Plasilová M; Pytlík R; Necas E
    Eur J Haematol; 2003 Mar; 70(3):143-50. PubMed ID: 12605658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells.
    Quirici N; Soligo D; Caneva L; Servida F; Bossolasco P; Deliliers GL
    Br J Haematol; 2001 Oct; 115(1):186-94. PubMed ID: 11722432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133+ cell content does not influence recovery time after hematopoietic stem cell transplantation.
    Jaime-Pérez JC; Guillermo-Villanueva VA; Méndez-Ramírez N; Chapa-Rodríguez A; Gutiérrez-Aguirre H; Gómez-Almaguer D
    Transfusion; 2009 Nov; 49(11):2390-4. PubMed ID: 19903294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of G-CSF-mobilized peripheral blood CD133+ progenitor cells on coculture with human stromal cells.
    Kawano Y; Kobune M; Chiba H; Nakamura K; Takimoto R; Takada K; Ito Y; Kato J; Hamada H; Niitsu Y
    Exp Hematol; 2006 Feb; 34(2):150-8. PubMed ID: 16459183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human placenta-derived Wnt-5a induces the expression of ICAM-1 and VCAM-1 in CD133(+)CD34(+)-hematopoietic progenitor cells.
    Herr F; Horndasch M; Howe D; Baal N; Goyal P; Fischer S; Zygmunt M; Preissner KT
    Reprod Biol; 2014 Dec; 14(4):262-75. PubMed ID: 25454492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
    Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
    Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiparametric flow cytometry analyzes the expressions of immunophenotype CD133, CD34, CD44 in lung cancer naive cells].
    Liu D; Li WM; Mo XM; Liu LX; Wang Y; Che GW; Wu Z; Gou JL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):827-31. PubMed ID: 19024325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.
    Peichev M; Naiyer AJ; Pereira D; Zhu Z; Lane WJ; Williams M; Oz MC; Hicklin DJ; Witte L; Moore MA; Rafii S
    Blood; 2000 Feb; 95(3):952-8. PubMed ID: 10648408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
    Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
    Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional profiling reflects shared and unique characters for CD34+ and CD133+ cells.
    Hemmoranta H; Hautaniemi S; Niemi J; Nicorici D; Laine J; Yli-Harja O; Partanen J; Jaatinen T
    Stem Cells Dev; 2006 Dec; 15(6):839-51. PubMed ID: 17253947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.